Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301119 · ClinicalTrials.gov registry record
Lung Cancer Biomarkers and Screening
A clinical trial of Lung Cancer, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 10,850
- Enrollment target
- 1
- Study location
NCT00301119: Recruiting study of Lung Cancer, sponsored by NYU Langone Health.
NCT00301119 is a study of Lung Cancer that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 10,850 participants, above the 909-participant average among 409 other Lung Cancer trials with a reported enrollment target (1094% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301119, a study of Lung Cancer, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 10,850 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Conditions Studied
Study Locations (1)
New York
- NYU Cancer Institute at New York University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,850 participants |
| Start Date | 2000-05 |
| Est. Completion | 2030-05 |
What NCT00301119 shows while recruiting
NCT00301119 is an observational study that tracks outcomes without assigning an intervention. Its 10,850 participants enrollment target places it among the larger protocols in the corpus, above the 909-participant average among 409 other Lung Cancer trials with a reported enrollment target (1094% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00301119 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00301119 about?
NCT00301119 is a clinical study titled "Lung Cancer Biomarkers and Screening". RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
What is the current status of trial NCT00301119?
This trial is currently recruiting. The enrollment target is 10,850 participants. The study started on 2000-05. Estimated completion is 2030-05.
What conditions does trial NCT00301119 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT00301119?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00301119 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00301119's enrollment target sits among peer trials
10,850 9th of 409 higher than 401 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia